Remove Intellectual Property Remove Ownership Remove Settlement Remove Webinar
article thumbnail

2023 Trade Secrets Webinar Series Recap: Key Takeaways and Access to Recordings

Trading Secrets

In 2023, Seyfarth’s Trade Secrets, Computer Fraud & Non-Compete practice group presented a series of dynamic and insightful CLE webinars, addressing pivotal challenges confronting businesses head-on. We’re excited to share that Continuing Legal Education (CLE) credit is attainable by watching the webinar recordings.

article thumbnail

2023 Trade Secrets Webinar Series Recap: Key Takeaways and Access to Recordings

LexBlog IP

In 2023, Seyfarth’s Trade Secrets, Computer Fraud & Non-Compete practice group presented a series of dynamic and insightful CLE webinars, addressing pivotal challenges confronting businesses head-on. We’re excited to share that Continuing Legal Education (CLE) credit is attainable by watching the webinar recordings.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Webinar Recap! FTC Proposes Rule Banning Use of Non-Competes. Now What?

LexBlog IP

In the first installment of our 2023 Trade Secrets & Non-Competes Webinar Series, Seyfarth partners Kate Perrelli, Michael Wexler, Robert Milligan, Dan Hart, and Dawn Mertineit discussed the new Federal Trade Commission’s (“FTC”) proposed rule banning the use of non-competes with employees and workers.

article thumbnail

SpicyIP Weekly Review (February 05- February 11)

SpicyIP

His passion lies in understanding the intersection of economics and public health with intellectual property rights. The Respondent operates his business through two incorporated entities and claims ownership of the trademark via the permitted use by the two incorporated entities. Chinmaya Golecha of Sequoia Capitala.

Trademark 103
article thumbnail

SpicyIP Weekly Review (September 25- October 1)

SpicyIP

Highlights of the Week Bayh Dole-esque Guidelines Notified by Dept of Biotechnology Image from here Earlier this month, Dept of Biotech notified the DBT IP Guidelines for ownership and commercialization of IP arising from DBT funded research outcomes. This comes nearly 10 years after the PUPFIP bill’s withdrawal.